Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of GSK's TB Vaccine 692342 in Infants
NCT01098474Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2010
- Primary completion
- Apr 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of M72 + AS01E in Tuberculosis (TB), sponsored by GSK. Started Jul 2010; status: completed.
02
Drugs
M72 + AS01E
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT01098474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01098474.